DISTRIBUTION OF RADIONUCLIDES IN RIVER SEDIMENTS OF KATHMANDU VALLEY, NEPAL AND THE EVALUATION OF ASSOCIATED RADIATION HAZARD.

The natural radioactivity in our living environment is mainly due to radionuclides of 40K, 232Th and 238U. We studied the distribution of these radionuclides in the sediment of different rivers and streams throughout the Kathmandu valley. The activity concentrations were determined by using digiBase NaI(TI) gamma-ray spectrometer, and further they were used to calculate radiological hazard indices to estimate the risk associated with the use of these sediments. The average activity concentrations for 40K, 232Th and 238U were found to be 378.54 ± 109.06, 45.95 ± 18.47 and 26.90 ± 9.61 Bq per kg, respectively. The average concentrations and calculated hazard indices have been compared with the respective reported activity concentration in different countries. This study reveals that there is no radiological threat using these local sediments as building materials and for other purposes.

An Unusual Case of Penetrating Injury Skull with Metallic RCC Rod in A Child - A Rare Case Scenario with Review of Literature.

Penetrating head injuries can be the result of numerous intentional or unintentional events, including missile wounds, stab wounds, and motor vehicle or occupational accidents (nails, screw-drivers). Penetrating head injuries in children constitute even a smaller part of the total number of traumatic head injuries seen in casualty. We report a case of neuro-trauma who was operated in our institution. A 6-year-old female presented in casualty with an iron rod penetrating into the skull.

Intramedullary mature teratoma of spinal cord: A rare tumor with review of literature.

BACKGROUND: Spinal teratomas are rare in adults. The clinical findings are nonspecific, reflecting only in the intramedullary location of these lesions. The potential differential diagnosis for intramedullary spinal teratomas include schwannomas, dermoids, epidermoids, and neurofibromas. CASE DESCRIPTION: A 25-year-old male presented with RLE weakness (iliopsoas/quadriceps [4/5], and extensor hallucis longus/dorsiflexor [0/5]) and urinary incontinence. As the contrast, MR showed a heterogeneous intramedullary lesion with well-defined edges located at the T12-L1 level, the patient underwent a focal laminectomy for gross total tumor excision. Pathologically, it proved to be a mature teratoma. CONCLUSION: Teratomas should be considered among the differential diagnostic considerations for intramedullary spinal cord lesions. Although gross total resection is preferred, these lesions have a low recurrence rate, and therefore, partial removal is also valid, where lesions are densely adherent to adjacent neural structures.

Solitary osteochondroma of dorsal spine causing canal stenosis with myelopathy - A case report with review of literature.

BACKGROUND: Osteochondroma is a common benign tumor arising from the long bones. It rarely arises in the spine, where it can cause mild symptoms such as backache all the way up to compressive myelopathy. Malignant transformation has also been reported. Here, the authors present a 52-year-old male with myelopathy attributed to a rare thoracic solitary osteochondroma. CASE DESCRIPTION: A 52-year-old male presented back pain radiating into both lower extremities with paresthesia to the toes of 1 year's duration. On examination, he exhibited hyperactive bilateral lower extremity reflexes with bilateral Babinski signs, and focal sensory changes to pin, and touch appreciation in the left L5S1 distributions. Computed tomography and magnetic resonance imaging showed an abnormal bony mass arising from the posterior arch of T10 with protrusion into the spinal canal resulting in marked canal/cord compression. Surgery included a D10 laminectomy with en bloc resection of the lesion. Postoperatively, the patient's symptoms resolved. Histologically, the lesion was an osteochondroma. CONCLUSION: When patients present with myelopathy, one should include osteochondromas among the differential diagnostic possibilities.

Cellular and molecular mechanisms of curcumin in prevention and treatment of disease.

Curcumin is a naturally occurring polyphenolic compound present in rhizome of Curcuma longa belonging to the family zingiberaceae. Growing experimental evidence revealed that curcumin exhibit multitarget biological implications signifying its crucial role in health and disease. The current review highlights the recent progress and mechanisms underlying the wide range of pharmacological effects of curcumin against numerous diseases like neuronal, cardiovascular, metabolic, kidney, endocrine, skin, respiratory, infectious, gastrointestinal diseases and cancer. The ability of curcumin to modulate the functions of multiple signal transductions are linked with attenuation of acute and chronic diseases. Numerous preclinical and clinical studies have revealed that curcumin modulates several molecules in cell signal transduction pathway including PI3K, Akt, mTOR, ERK5, AP-1, TGF-ß, Wnt, ß-catenin, Shh, PAK1, Rac1, STAT3, PPARγ, EBPα, NLRP3 inflammasome, p38MAPK, Nrf2, Notch-1, AMPK, TLR-4 and MyD-88. Curcumin has a potential to prevent and/or manage various diseases due to its anti-inflammatory, anti-oxidant and anti-apoptotic properties with an excellent safety profile. In contrast, the anti-cancer effects of curcumin are reflected due to induction of growth arrest and apoptosis in various premalignant and malignant cells. This review also carefully emphasized the pharmacokinetics of curcumin and its interaction with other drugs. Clinical studies have shown that curcumin is safe at the doses of 12 g/day but exhibits poor systemic bioavailability. The use of adjuvant like piperine, liposomal curcumin, curcumin nanoparticles and curcumin phospholipid complex has shown enhanced bioavailability and therapeutic potential. Further studies are warranted to prove the potential of curcumin against various ailments.

Medicinal plants with acetylcholinesterase inhibitory activity.

Alzheimer's disease, a progressive neurodegenerative disease, is characterised by hypofunction of acetylcholine (ACh) neurotransmitter in the distinct region of brain. Acetylcholinesterase (AChE) is an enzyme that metabolises the ACh at synaptic cleft resulting in Alzheimer's disease. Medicinal plants have been used to treat numerous ailments and improve human health from ancient time. A traditional system of medicine is long recognised for its effective management of neurological disorders. The present review confers the scope of some common medicinal plants with a special focus on AChE-mediated central nervous system complications especially Alzheimer's disease. Literature suggests that medicinal plants reduce neuronal dysfunctions by reducing AChE activity in different brain regions. In some instances, activation of AChE activity by medicinal plants also showed therapeutic potential. In conclusion, medicinal plants have a wide scope and possess therapeutic potential to efficiently manage neurological disorders associated with AChE dysregulation.